Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05230810
Title Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Criterium, Inc.
Indications

Her2-receptor positive breast cancer

Therapies

Alpelisib + Fulvestrant + Tucatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST